48830 Federal Register / Vol. 82, No. 202 / Friday, October 20, 2017 / Notices 

requirements, (3) exemption from 

animal food CGMP requirements, and 

(4) exemption from animal food 

preventive controls requirements. 

This draft guidance, when finalized, 

will clarify that if all of the activities 

performed by an establishment are 

exempt under one or more CGMP 

exemptions, then the establishment is 

not subject to the part 117 and/or part 

507 CGMPs, as applicable. If all the 

activities performed by a facility are 

exempt under one or more preventive 

controls exemptions, then the facility is 

not subject to the part 117 and/or part 

507 preventive controls requirements, as 

applicable. If all the activities performed 

by a facility are exempt under one or 

more CGMP exemptions and one or 

more preventive controls exemptions, 

then the facility is not subject to the 

CGMP or preventive controls 

requirements in part 117 and/or part 

507, as applicable. 

II. Electronic Access 

Persons with access to the internet 

may obtain the draft guidance at either 

https://www.fda.gov/FoodGuidances or 

https://www.fda.gov/ForIndustry/ 

ColorAdditives/

GuidanceComplianceRegulatory

Information/ucm153033.htm 

(whichever is applicable) or https://

www.regulations.gov. Use the FDA Web 

site listed in the previous sentence to 

find the most current version of the 

guidance. 

Dated: October 16, 2017. 

Anna K. Abram, 

Deputy Commissioner for Policy, Planning, 

Legislation, and Analysis. 

[FR Doc. 2017–22731 Filed 10–19–17; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Program 

Project: Cell Biology. 

Date: November 9, 2017. 

Time: 11:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: David Balasundaram, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5189, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1022, balasundaramd@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Radiation Therapy and Biology. 

Date: November 14–15, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Bo Hong, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health. 6701 Rockledge 

Drive, Room 6194, MSC 7804, Bethesda, MD 

20892, 301–996–6208, hongb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; National 

Swine Resource and Research center review. 

Date: November 14, 2017. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Katherine M. Malinda, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4140, 

MSC 7814, Bethesda, MD 20892, 301–435– 

0912, Katherine_Malinda@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Disease 

Prevention and Management, Risk Reduction 

and Health Behavior Change. 

Date: November 16–17, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Monaco, 2 North Charles 

Street, Baltimore, MD 21201. 

Contact Person: Michael John McQuestion, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

Bethesda, MD 20892, 301–480–1276, 

mike.mcquestion@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Aging and Development, Auditory, 

Vision and Low Vision Technologies. 

Date: November 16–17, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Darcy Washington DC, 1515 

Rhode Island Ave. NW., Washington, DC 

20005. 

Contact Person: Paek-Gyu Lee, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4201, 

MSC 7812, Bethesda, MD 20892, (301) 613– 

2064, leepg@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Cancer Biotherapeutics 

Development. 

Date: November 16–17, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn San Antonio Riverwalk, 

217 N St. Mary’s, San Antonio, TX 78205. 

Contact Person: Nicholas J. Donato, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040, 

Bethesda, MD 20817, 301–827–4810, 

nick.donato@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Cancer Drug Development and 

Therapeutics. 

Date: November 16–17, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn San Antonio Riverwalk, 

217 North St. Mary’s, San Antonio, TX 

78205. 

Contact Person: Lilia Topol, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20892, 301–451– 

0131, ltopol@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Medical Imaging. 

Date: November 16–17, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Mark Center, 

5000 Seminary Road, Alexandria, VA 22311. 

Contact Person: Leonid V. Tsap, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5128, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

2507, tsapl@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group; AIDS 

Discovery and Development of Therapeutics 

Study Section. 

Date: November 16, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Mayflower Park Hotel, 405 Olive 

Way, Seattle, WA 98101. 

Contact Person: Shiv A. Prasad, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5220, 

MSC 7852, Bethesda, MD 20892, 301–443– 

5779, prasads@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 


srobinson on DSKBC5CHB2PROD with NOTICES
Federal Register / Vol. 82, No. 202 / Friday, October 20, 2017 / Notices 48831 

Business: Clinical Neurophysiology, Devices, 

Neuroprosthetics, and Biosensors. 

Date: November 16–17, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Washington, DC, 

Dupont Circle, 1143 New Hampshire Avenue 

NW., Washington, DC 20037. 

Contact Person: Cristina Backman, Ph.D., 

Scientific Review Officer, ETTN IRG, Center 

for Scientific Review National Institutes of 

Health, 6701 Rockledge Drive, Room 5211, 

MSC 7846, Bethesda, MD 20892, 301–480– 

9069, cbackman@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Non-HIV Microbial Vaccines. 

Date: November 16, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Andrea Keane-Myers, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4218, 

Bethesda, MD 20892, 301–435–1221, 

andrea.keane-myers@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Drug Discovery for Aging, 

Neuropsychiatric and Neurologic Disorders. 

Date: November 16–17, 2017. 

Time: 8:00 a.m. to 2:00 p.m. 

Time: To review and evaluate grant 

applications. 

Place: Residence Inn Arlington Pentagon 

City, 550 Army Navy Drive, Arlington, VA 

22202. 

Contact Person: Joseph G. Rudolph, Ph.D., 

Chief and Scientific Review Officer, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7844, Bethesda, MD 20892, 301–408– 

9098, josephru@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Cell Biology, Developmental 

Biology, and Bioengineering. 

Date: November 16–17, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Time: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Alexander Gubin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4196, 

MSC 7812, Bethesda, MD 20892, 301–435– 

2902, gubina@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Non-HIV Diagnostics, Food Safety, 

Sterilization/Disinfection, and 

Bioremediation. 

Date: November 16–17, 2017. 

Time: 8:00 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Gagan Pandya, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, Center for Scientific Review, 6701 

Rockledge Drive, RM 3200, MSC 7808, 

Bethesda, MD 20892, 301–435–1167, 

pandyaga@mail.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group; 

NeuroAIDS and other End-Organ Diseases 

Study Section. 

Date: November 16, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street NW., Washington, DC 20037. 

Contact Person: Eduardo A. Montalvo, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1168, montalve@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Reproductive and Perinatal Biology. 

Date: November 16, 2017. 

Time: 1:00 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Gregory S. Shelness, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6156, 

Bethesda, MD 20892–7892, (301) 435–0492, 

shelnessgs@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Diabetes 

and Obesity: Integrative Physiology and 

Cellular Aspect Topics. 

Date: November 16, 2017. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Hui Chen, MD., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 6164, Bethesda, MD 20892, 301– 

435–1044, chenhui@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Skeletal Biology, Pathogenesis, and 

Regeneration. 

Date: November 16, 2017. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Yi-Hsin Liu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1781, liuyh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Cardiovascular and Surgical 

Devices. 

Date: November 17, 2017. 

Time: 7:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Alexandria Old 

Town, 1900 Diagonal Rd., Alexandria, VA 

22314. 

Contact Person: Jan Li, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5106, 

Bethesda, MD 20892, 301–402–9607, Jan.Li@

nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group; HIV/ 

AIDS Vaccines Study Section. 

Date: November 17, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westgate Hotel, 1055 Second 

Avenue, San Diego, CA 92101. 

Contact Person: Barna Dey, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3184, 

Bethesda, MD 20892, 301–435–0000, bdey@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Addictions, Depression, Bipolar 

Disorder, and Schizophrenia. 

Date: November 17, 2017. 

Time: 8:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kristin Kramer, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5205, 

MSC 7846, Bethesda, MD 20892, (301) 437– 

0911, kramerkm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 16– 

433—Support of NIGMS Program Project 

Grants. 

Date: November 17, 2017. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Luis Dettin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2208, 

Bethesda, MD 20892, 301–451–1327, 

dettinle@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Topics in 

Antimicrobial Resistance, Drug Discovery 

and Clinical Field Studies. 

Date: November 17, 2017. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Marci Scidmore, Ph.D., 

Scientific Review Officer, Center for 


srobinson on DSKBC5CHB2PROD with NOTICES
48832 Federal Register / Vol. 82, No. 202 / Friday, October 20, 2017 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7808, Bethesda, MD 20892, 301–435– 

1149, marci.scidmore@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR: 

Development of Appropriate Pediatric 

Formulations and Pediatric Drug Delivery 

Systems. 

Date: November 17, 2017. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Arlington Pentagon 

City, 550 Army Navy Drive, Arlington, VA 

22202. 

Contact Person: Joseph G. Rudolph, Ph.D., 

Chief and Scientific Review Officer, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7844, Bethesda, MD 20892, 301–408– 

9098, josephru@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 13, 2017. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–22725 Filed 10–19–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Charter Renewal 

It is determined that the National 

Cancer Institute Board of Scientific 

Advisors is in the public interest in 

connection with the performance of 

duties imposed on the National Cancer 

Institute and National Institutes of 

Health by law, and that these duties can 

best be performed through the advice 

and counsel of this group. 

In accordance with Title 41 of the 

U.S. Code of Federal Regulations, 

Section 102–3.65(a), notice is hereby 

given that the Charter for the National 

Cancer Institute Board of Scientific 

Advisors was renewed for an additional 

two-year period on October 8, 2017. 

Inquiries may be directed to Anna 

Snouffer, Acting Director, Office of 

Federal Advisory Committee Policy, 

Office of the Director, National 

Institutes of Health, 6701 Democracy 

Boulevard, Suite 1000, Bethesda, 

Maryland 20892 (Mail code 4875), 

Telephone (301) 496–2123, or 

snouffea@od.nih.gov. 

Dated: October 17, 2017. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–22824 Filed 10–19–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Evaluation and Testing 

Services for Vaccines and Other Biologics for 

Diseases (N01). 

Date: November 14, 2017. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Annie Walker-Abbey, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, NIAID/NIH/DHHS, 5601 

Fishers Lane, Room 3E70A, Rockville, MD 

20852, 240–627–3390, aabbey@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: October 17, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–22825 Filed 10–19–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

A—Cancer Centers. 

Date: November 30–December 1, 2017. 

Time: 6:00 p.m. to 2:25 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Cambria Suites Rockville, 1 Helen 

Heneghan Way, Rockville, MD 20850. 

Contact Person: Shamala K. Srinivas, 

Ph.D., Scientific Review Officer, Office of 

Referral, Review, and Program Coordination, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W530, Bethesda, MD 20892– 

9750, 240–276–6442, ss537t@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel Cancer 

Center Support Grant (P30). 

Date: December 1, 2017. 

Time: 2:30 p.m. to 4:15 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Cambria Suites, Rockville, 1 Helen 

Heneghan Way, Rockville, MD 20850. 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W234, Bethesda, MD 20892–9750, 

240–276–6368, Stoicaa2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 16, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–22729 Filed 10–19–17; 8:45 am] 

BILLING CODE 4140–01–P 


srobinson on DSKBC5CHB2PROD with NOTICES